Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nicolas Malvaux"'
Autor:
Nicolas Malvaux, Fanette Defraigne, Styliani Bartziali, Camille Bellora, Kathleen Mommaerts, Fay Betsou, Anne Schuhmacher
Publikováno v:
Pathogens, Vol 11, Iss 3, p 343 (2022)
Background and Objectives: Since 2015, platelet products have been pathogen-inactivated (PI) at the Luxemburgish Red Cross (LRC) using Riboflavin and UV light (RF-PI). As the LRC should respond to hospital needs at any time, platelet production excee
Externí odkaz:
https://doaj.org/article/cc3ad1ecc98d4f7fada9729dca5f680f
Publikováno v:
Transfusion Clinique et Biologique. 28:S41-S42
Autor:
Mélanie Abonnenc, Anne Schuhmacher, André Rapaille, Nicolas Malvaux, Anaïs Lotens, Michel Prudent
Publikováno v:
Vox sanguinisReferences. 116(1)
BACKGROUND AND OBJECTIVES The antioxidant power measurement can be useful to validate the execution of the pathogen inactivation treatment of platelet concentrates. The aim of this study is to evaluate the technology on different blood preparations i
Autor:
Marcia da Silva Cardoso, Remy Jacob, Fanette Defraigne, Anne Schuhmacher, Aicha Bah, Nicolas Malvaux
Publikováno v:
Transfusion and Apheresis Science. 60:103195
In 2014–2015, the Luxembourg Red Cross (LRC) implemented a fully automated system (FAS) able to process 4 whole blood units simultaneously, and a pathogen reduction technology (PRT) based on riboflavin and ultraviolet light to improve safety of pla